Moreover, GLP-1RA negatively influences the expression of peroxisome proliferator-activated receptors (PPARs), leading to a downregulation of proteins associated with lipid metabolism (37, 41, 42)
Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia
This dual mechanism results in substantial improvements in glycemic control and body weightclinical trials demonstrated average weight loss of 15-21% over 72 weeks, significantly exceeding results from single GLP-1 agonists
Multiple Reddit users who restarted at their prior dose reported significantly worse nausea than on their first titration, which is consistent with GI hypersensitivity after a drug-free interval
Bezin, J., Gouverneur, A., Penichon, M., Mathieu, C., Garrel, R., Hillaire-Buys, D., Pariente, A., & Faillie, J
This is a significant amount of weight loss, and its important to note that individual factors such as starting weight, diet, and exercise habits can all influence results